NCT01166854 Characterization of Familial Myopathy and Paget Disease of Bone
| NCT ID | NCT01166854 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Irvine |
| Condition | Muscle Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2010-06-18 |
| Primary Completion | 2030-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25 participants in total. It began in 2010-06-18 with a primary completion date of 2030-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The researcher wants to explore the genetic causes of muscle disease. The researcher is particularly interested in muscle disorders that occur in combination with diseases of bone that appear to be passed on from generation to generation. Diffuse Optical Spectroscopy will measure the concentrations of blood, water, and lipids (fats, for example) in your tissues. This device essentially measures the color of tissues in order to determine tissue physiology (its physical and chemical processes).
Eligibility Criteria
Inclusion Criteria: Male or Female age 18 and older * diagnose of Muscle or bone disorders * with a combination of medical problems including muscle and bone disease and their family members. Exclusion Criteria: * under 18 year of age * unrelated diagnosis
Contact & Investigator
Virginia Kimonis, MD
PRINCIPAL INVESTIGATOR
Beckman Laser Institute University of California Irvine
Frequently Asked Questions
Who can join the NCT01166854 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Muscle Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01166854 currently recruiting?
Yes, NCT01166854 is actively recruiting participants. Contact the research team at mwencel@uci.edu for enrollment information.
Where is the NCT01166854 trial being conducted?
This trial is being conducted at Irvine, United States.
Who is sponsoring the NCT01166854 clinical trial?
NCT01166854 is sponsored by University of California, Irvine. The principal investigator is Virginia Kimonis, MD at Beckman Laser Institute University of California Irvine. The trial plans to enroll 25 participants.